Low-dose radiation shows promise as treatment for brain injury and stroke

Traumatic brain injury (TBI) and ischemic stroke are major public health concerns and leading causes of death and disability worldwide.

Bavarian Nordic seeks authorisation for mpox vaccine’s use in adolescents – Pharmaceutical Technology

Bavarian Nordic’s mpox vaccine is currently only indicated for adults 18 years and older. Image credit: Shutterstock/ Riccardo Mayer. Amid the ongoing global mpox public

August 16, 2024

FDA thwarts Agenus’ accelerated approval plans for CTLA-4/PD-1 combo in ‘disappointing’ move

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 19, 2024

Four Might Be the Magic Number for Anticoagulation of Subclinical Afib

BOSTON — In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for

May 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.